SOLVNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Solventum Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$85.05−0.76 (-0.89%)
Close on Oct 19, 2026
- Market cap
- $14.74B
- P/E (TTM)
- 10.4
- Dividend yield
- –
Solventum Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 54.7%
- Operating margin
- 25.0%
- Net margin
- 17.3%
- Return on equity, FY2025
- 38.9%
Financial strength
- Current ratio
- 1.02
- Debt to equity
- 1.06
- Debt to assets
- 35.7%
- Cash to current liabilities
- 11.0%
Valuation
- P/E ratio
- 10.4
- Price to sales
- 1.77
- Price to book
- 3.07
- Dividend yield
- –